{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:16:08Z","timestamp":1783016168854,"version":"3.54.6"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Interdisciplinary Centre for Clinical Research (IZKF) W\u00fcrzburg"},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203971\/Z\/16\/Z"],"award-info":[{"award-number":["203971\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Free State of Bavaria","award":["COVID-19 research funds"],"award-info":[{"award-number":["COVID-19 research funds"]}]},{"name":"German Federal Ministry of Education and Research","award":["Network University Medicine (NUM): \u201eNaFoUniMedCovid19\u201c Grant No: 01KX2021, Project: \u201cBundesweites Forschungsnetz Angewandte Surveillance und Testung\u201d (B-FAST)"],"award-info":[{"award-number":["Network University Medicine (NUM): \u201eNaFoUniMedCovid19\u201c Grant No: 01KX2021, Project: \u201cBundesweites Forschungsnetz Angewandte Surveillance und Testung\u201d (B-FAST)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Oral contraceptives (OCs) can substantially modulate immune responses; however, their impact on vaccine immunogenicity remains poorly understood. This study investigated OC use patterns and their determinants among healthcare workers (HCWs), and the effects of OCs on humoral and T-cell-mediated immune responses following COVID-19 booster vaccination. From 29 September 2021 to 31 December 2023, 1061 female HCWs aged 18-50 years were enrolled in the CoVacSer study. OC users were compared to non-users. Blood samples combined with a questionnaire were collected before and after third and fourth COVID-19 vaccination including follow-ups. Anti-SARS-CoV-2-Spike IgG levels were measured using SERION ELISA\n                    <jats:italic>agile<\/jats:italic>\n                    SARS-CoV-2 IgG, T-cellular immune response using Oxford Immunotec T-SPOT\u00ae.COVID. A linear mixed and a generalised linear model were used to assess the influence of OC on post-vaccination immune response. At study inclusion, 21.7% (230\/1061) reported OC use. Younger age, being a physician, and higher BMI were significantly associated with OC. Linear mixed and generalised linear regression models revealed no significant association between reported OC use and humoral and T-cellular immune response before and after COVID-19 vaccination. Although OC are known to modulate immune responses, this study found no statistically significant association between self-reported OC use and humoral or cellular immunogenicity following COVID-19 vaccination. This is among the first studies to address this in the context of COVID-19 booster vaccination. Our findings suggest that in women using OC no specific adjustments to COVID-19 vaccination strategies are required considering OC use. Continued investigation of potential interactions between OC and vaccine- or infection-induced immunity remain warranted.\n                  <\/jats:p>","DOI":"10.1038\/s41541-026-01510-z","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:05:13Z","timestamp":1783011913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oral contraceptive usage among healthcare workers and its impact on COVID-19 booster vaccination immunogenicity"],"prefix":"10.1038","volume":"11","author":[{"given":"Isabell","family":"Wagenh\u00e4user","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Reusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Mees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas B.","family":"Krone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Eiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi\u00ean-Tr\u00ed","family":"L\u00e2m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Schubert-Unkmeir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Curtaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Kurzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Frantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Wicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"W\u00f6ckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Petri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Gabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1020-6454","authenticated-orcid":false,"given":"Manuel","family":"Krone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"1510_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0140-6736(22)00936-9","volume":"400","author":"A Haakenstad","year":"2022","unstructured":"Haakenstad, A. et al. Measuring contraceptive method mix, prevalence, and demand satisfied by age and marital status in 204 countries and territories, 1970\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 400, 295\u2013327 (2022).","journal-title":"Lancet"},{"key":"1510_CR2","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1001\/jama.2021.21392","volume":"326","author":"S Teal","year":"2021","unstructured":"Teal, S. & Edelman, A. Contraception Selection, Effectiveness, and Adverse Effects: A Review. JAMA 326, 2507\u20132518 (2021).","journal-title":"JAMA"},{"key":"1510_CR3","unstructured":"United Nations (Department of Economic and Social Affairs): Contraceptive Use by Method, <https:\/\/www.un.org\/development\/desa\/pd\/sites\/www.un.org.development.desa.pd\/files\/files\/documents\/2020\/Jan\/un_2019_contraceptiveusebymethod_databooklet.pdf (Accessed 31 March 2024)> (2019)."},{"key":"1510_CR4","unstructured":"Bundesministerium der Justiz: Sozialgesetzbuch (SGB) F\u00fcnftes Buch (V) - Gesetzliche Krankenversicherung - (Artikel 1 des Gesetzes v. 20. Dezember 1988, BGBl. I S. 2477) \u00a7 24a Empf\u00e4ngnisverh\u00fctung, <https:\/\/www.gesetze-im-internet.de\/sgb_5\/__24a.html> (1988)."},{"key":"1510_CR5","unstructured":"AOK-Bundesverband. Die Gesundheitskasse: Pressemitteilung: Immer weniger junge Frauen verh\u00fcten mit der klassischen Pille, <https:\/\/www.aok.de\/pp\/bv\/pm\/2021-weniger-verhuetung-mit-pille\/ (Accessed 31 March 2023)> (2022)."},{"key":"1510_CR6","unstructured":"Bundeszentrale f\u00fcr gesundheitliche Aufkl\u00e4rung (BZgA): Verh\u00fctungsverhalten Erwachsener 2023 (Repr\u00e4sentative BZgA-Wiederholungsbefragung), <https:\/\/www.bzga.de\/fileadmin\/user_upload\/PDF\/pressemitteilungen\/daten_und_fakten\/Infoblatt_BZgA-Studiendaten_Verh\u00fctungsverhalten_2023.pdf (Accessed 31 March 2024)> (2023)."},{"key":"1510_CR7","unstructured":"Bundeszentrale f\u00fcr gesundheitliche Aufkl\u00e4rung (BZgA): Verh\u00fctungsverhalten Erwachsener und Jugendlicher in Deutschland, <https:\/\/www.bzga.de\/fileadmin\/user_upload\/PDF\/pressemitteilungen\/daten_und_fakten\/info-blatt_verhuetungskongress--f9609343865f80c929996deb8b5f38a9.pdf (Accessed 31 March 2024)> (2011)."},{"key":"1510_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.contraception.2022.04.012","volume":"111","author":"KS Soin","year":"2022","unstructured":"Soin, K. S., Yeh, P. T., Gaffield, M. E., Ge, C. & Kennedy, C. E. Health workers\u2019 values and preferences regarding contraceptive methods globally: A systematic review. Contraception 111, 61\u201370 (2022).","journal-title":"Contraception"},{"key":"1510_CR9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.26719\/2013.19.6.547","volume":"19","author":"M Sattari","year":"2013","unstructured":"Sattari, M., Mokhtari, Z., Jabari, H. & Mashayekhi, S. O. Knowledge, attitude and practice of pharmacists and health-care workers regarding oral contraceptives correct usage, side-effects and contraindications. East Mediterr. Health J. 19, 547\u2013554 (2013).","journal-title":"East Mediterr. Health J."},{"key":"1510_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40834-024-00274-y","volume":"9","author":"K Opiro","year":"2024","unstructured":"Opiro, K. et al. Utilization of modern contraceptives among female health care workers at Gulu university teaching hospitals in Northern Uganda. Contracept. Reprod. Med. 9, 13 (2024).","journal-title":"Contracept. Reprod. Med."},{"key":"1510_CR11","doi-asserted-by":"publisher","first-page":"e2143730","DOI":"10.1001\/jamanetworkopen.2021.43730","volume":"5","author":"S Brabaharan","year":"2022","unstructured":"Brabaharan, S. et al. Association of Hormonal Contraceptive Use With Adverse Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials and Cohort Studies. JAMA Netw. Open 5, e2143730\u2013e2143730 (2022).","journal-title":"JAMA Netw. Open"},{"key":"1510_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/00243639.2017.1360065","volume":"84","author":"WV Williams","year":"2017","unstructured":"Williams, W. V. Hormonal Contraception and the Development of Autoimmunity: A Review of the Literature. Linacre Q. 84, 275\u2013295 (2017).","journal-title":"Linacre Q."},{"key":"1510_CR13","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.1111\/bcp.14840","volume":"87","author":"YS Rosenthal","year":"2021","unstructured":"Rosenthal, Y. S. et al. Association between oral contraceptives and serious infections: A population-based cohort study. Br. J. Clin. Pharmacol. 87, 4241\u20134251 (2021).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"1510_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0015-0282(02)03173-4","volume":"78","author":"L Auerbach","year":"2002","unstructured":"Auerbach, L., Hafner, T., Huber, J. C. & Panzer, S. Influence of low-dose oral contraception on peripheral blood lymphocyte subsets at particular phases of the hormonal cycle. Fertil. Steril. 78, 83\u201389 (2002).","journal-title":"Fertil. Steril."},{"key":"1510_CR15","doi-asserted-by":"publisher","unstructured":"Notbohm, H. L., Umlauff, L., Bloch, W. & Schumann, M. Comparison of the cytokine responses to acute strength exercise between oral contraceptive users and naturally cycling women. European Journal of Applied Physiology https:\/\/doi.org\/10.1007\/s00421-023-05275-4 (2023).","DOI":"10.1007\/s00421-023-05275-4"},{"key":"1510_CR16","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/mi.2017.35","volume":"10","author":"OJ Hall","year":"2017","unstructured":"Hall, O. J. & Klein, S. L. Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites. Mucosal Immunol. 10, 1097\u20131107 (2017).","journal-title":"Mucosal Immunol."},{"key":"1510_CR17","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0010-7824(84)80013-X","volume":"29","author":"DA Baker","year":"1984","unstructured":"Baker, D. A. & Thomas, J. The effect of low dose oral contraceptives on the initial immune response to infection. Contraception 29, 519\u2013525 (1984).","journal-title":"Contraception"},{"key":"1510_CR18","doi-asserted-by":"publisher","first-page":"303.e301","DOI":"10.1016\/j.ajog.2021.03.023","volume":"225","author":"KJ Gray","year":"2021","unstructured":"Gray, K. J. et al. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study. Am. J. Obstet. Gynecol. 225, 303.e301\u2013303.e317 (2021).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1510_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.13929","volume":"n\/a","author":"I Wagenh\u00e4user","year":"2023","unstructured":"Wagenh\u00e4user, I. et al. The relationship between mental health, sleep quality and the immunogenicity of COVID-19 vaccinations. J. Sleep. Res. n\/a, e13929. https:\/\/doi.org\/10.1111\/jsr.13929 (2023).","journal-title":"J. Sleep. Res."},{"key":"1510_CR20","unstructured":"European Medicines Agency (EMA): Authorised COVID-19 vaccines, <https:\/\/www.ema.europa.eu\/en\/human-regulatory\/overview\/public-health-threats\/coronavirus-disease-covid-19\/treatments-vaccines\/vaccines-covid-19\/covid-19-vaccines-authorised#authorised-covid-19-vaccines-section (Accessed 16 July 2025)> (2025)."},{"key":"1510_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris, P. A. et al. The REDCap consortium: Building an international community of software platform partners. J. Biomed. Inf. 95, 103208 (2019).","journal-title":"J. Biomed. Inf."},{"key":"1510_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris, P. A. et al. Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform. 42, 377\u2013381 (2009).","journal-title":"J. Biomed. Inform."},{"key":"1510_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/oem.2008.039883","volume":"66","author":"TIJ van den Berg","year":"2009","unstructured":"van den Berg, T. I. J., Elders, L. A. M., de Zwart, B. C. H. & Burdorf, A. The effects of work-related and individual factors on the Work Ability Index: a systematic review. Occup. Environ. Med. 66, 211 (2009).","journal-title":"Occup. Environ. Med."},{"key":"1510_CR24","first-page":"809","volume":"4","author":"A Gholami","year":"2013","unstructured":"Gholami, A., Jahromi, L. M., Zarei, E. & Dehghan, A. Application of WHOQOL-BREF in Measuring Quality of Life in Health-Care Staff. Int J. Prev. Med 4, 809\u2013817 (2013).","journal-title":"Int J. Prev. Med"},{"key":"1510_CR25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0022-3999(99)00051-3","volume":"47","author":"SM Skevington","year":"1999","unstructured":"Skevington, S. M. Measuring quality of life in britain: Introducing the WHOQOL-100. J. Psychosom. Res. 47, 449\u2013459 (1999).","journal-title":"J. Psychosom. Res."},{"key":"1510_CR26","doi-asserted-by":"publisher","first-page":"2201390","DOI":"10.1183\/13993003.01390-2022","volume":"61","author":"I Wagenh\u00e4user","year":"2023","unstructured":"Wagenh\u00e4user, I. et al. Immunogenicity and safety of coadministration of COVID-19 and influenza vaccination. Eur. Respiratory J. 61, 2201390 (2023).","journal-title":"Eur. Respiratory J."},{"key":"1510_CR27","doi-asserted-by":"publisher","first-page":"e00319","DOI":"10.1128\/JCM.00319-21","volume":"59","author":"M Krone","year":"2021","unstructured":"Krone, M. et al. Performance of Three SARS-CoV-2 Immunoassays, Three Rapid Lateral Flow Tests, and a Novel Bead-Based Affinity Surrogate Test for the Detection of SARS-CoV-2 Antibodies in Human Serum. J. Clin. Microbiol. 59, e00319\u2013e00321 (2021).","journal-title":"J. Clin. Microbiol."},{"key":"1510_CR28","doi-asserted-by":"publisher","unstructured":"Wagenh\u00e4user, I. et al. Heterologous and homologous COVID-19 mRNA vaccination schemes for induction of basic immunity show similar immunogenicity regarding long-term spike-specific cellular immunity in healthcare workers. Vaccine, 126132 https:\/\/doi.org\/10.1016\/j.vaccine.2024.07.033 (2024).","DOI":"10.1016\/j.vaccine.2024.07.033"},{"key":"1510_CR29","doi-asserted-by":"publisher","first-page":"105158","DOI":"10.1016\/j.jcv.2022.105158","volume":"150-151","author":"WA Mak","year":"2022","unstructured":"Mak, W. A., Koeleman, J. G. M. & Ong, D. S. Y. Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot\u00ae Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals. J. Clin. Virol. 150-151, 105158 (2022).","journal-title":"J. Clin. Virol."},{"key":"1510_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jinf.2021.12.003","volume":"84","author":"WA Mak","year":"2022","unstructured":"Mak, W. A., Koeleman, J. G. M., van der Vliet, M., Keuren, F. & Ong, D. S. Y. SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: A prospective cohort study. J. Infect. 84, 171\u2013178 (2022).","journal-title":"J. Infect."},{"key":"1510_CR31","doi-asserted-by":"publisher","first-page":"113278","DOI":"10.1016\/j.jim.2022.113278","volume":"506","author":"F Nadat","year":"2022","unstructured":"Nadat, F. et al. Fresh versus frozen PMBC using the SARS CoV-2 T-SPOT.COVID test. Which works best? J. Immunol. Methods 506, 113278 (2022).","journal-title":"J. Immunol. Methods"},{"key":"1510_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijid.2021.09.073","volume":"113","author":"M Kruse","year":"2021","unstructured":"Kruse, M. et al. Performance of the T-SPOT(\u00ae).COVID test for detecting SARS-CoV-2-responsive T cells. Int J. Infect. Dis. 113, 155\u2013161 (2021).","journal-title":"Int J. Infect. Dis."},{"key":"1510_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1214\/ss\/1009213286","volume":"16","author":"L Brown","year":"2001","unstructured":"Brown, L., Cai, T. & DasGupta, A. Interval Estimation for a Binomial Proportion. Stat. Sci. 16, 101\u2013133 (2001).","journal-title":"Stat. Sci."},{"key":"1510_CR34","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1214\/aos\/1013699998","volume":"29","author":"Y Benjamini","year":"2001","unstructured":"Benjamini, Y. & Yekutieli, D. The Control of the False Discovery Rate in Multiple Testing under Dependency. Ann. Stat. 29, 1165\u20131188 (2001).","journal-title":"Ann. Stat."},{"key":"1510_CR35","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1001\/jamainternmed.2021.1635","volume":"181","author":"MC Cusimano","year":"2021","unstructured":"Cusimano, M. C. et al. Delay of Pregnancy Among Physicians vs Nonphysicians. JAMA Inte RNA Med. 181, 905\u2013912 (2021).","journal-title":"JAMA Inte RNA Med."},{"key":"1510_CR36","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.4049\/jimmunol.0901155","volume":"185","author":"LA Jones","year":"2010","unstructured":"Jones, L. A. et al. Differential Modulation of TLR3- and TLR4-Mediated Dendritic Cell Maturation and Function by Progesterone. J. Immunol. 185, 4525\u20134534 (2010).","journal-title":"J. Immunol."},{"key":"1510_CR37","unstructured":"Bayerisches Landesamt f\u00fcr Gesundheit und Lebensmittelsicherheit: \u00dcbersicht der Fallzahlen von Coronavirusinfektionen in Bayern, <https:\/\/www.lgl.bayern.de\/gesundheit\/infektionsschutz\/infektionskrankheiten_a_z\/coronavirus\/karte_coronavirus\/ (Accessed 31 December 2023)> (2023)."},{"key":"1510_CR38","unstructured":"Robert Koch-Institut (RKI): Anzahl und Anteile von VOC und VOI in Deutschland, <https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Daten\/VOC_VOI_Tabelle.html (Accessed 23 October 2023)> (2023)."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01510-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01510-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01510-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:17:27Z","timestamp":1783012647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01510-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1510"],"URL":"https:\/\/doi.org\/10.1038\/s41541-026-01510-z","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Author MK receives honoraria and research grants from GSK and Sanofi, as well as non-financial support from Euroimmun unrelated to this work. Author IW has received travel support from Swedish Orphan Biovitrum AB outside this work. Author IW is an 2026\/27 editorial fellow in the Editorial Board of Clinical Microbiology and Infection. All other authors declare no financial or non-financial competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Artificial intelligence (AI) was used for language improvement purposes only. The tools ChatGPT (OpenAI, San Francisco CA, USA) and DeepL (DeepL SE, Cologne, Germany) were used. The actual writing of the manuscript was carried out solely by the authors mentioned by name.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Use the artificial intelligence (AI) in the writing process"}}],"article-number":"134"}}